Disparities in the provision of sexually transmitted disease and pregnancy testing and prophylaxis for sexually assaulted women in Rhode Island emergency departments

Journal of Women's Health

Volumn 17, Issue 4, 2008, Pages 619-629

  Merchant, Roland C ^a,b   Phillips, Benjamin Z ^a   Delong, Allison K ^a   Mayer, Kenneth H ^a   Becker, Bruce M ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIASIS; EMERGENCY CONTRACEPTION; EMERGENCY WARD; FEMALE; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ORAL SEXUAL CONTACT; PREGNANCY TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUAL CRIME; SEXUALLY TRANSMITTED DISEASE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; CRIME VICTIMS; EMERGENCY SERVICE, HOSPITAL; EMERGENCY TREATMENT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PREGNANCY TESTS; PRIMARY PREVENTION; QUALITY ASSURANCE, HEALTH CARE; RAPE; RETROSPECTIVE STUDIES; RHODE ISLAND; SEXUALLY TRANSMITTED DISEASES; WOMEN'S HEALTH;

EID: 43049085934     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0472     Document Type: Article

References (19)

1. Federal Bureau of Investigation. Crime in the United States, 2005: Uniform crime reports. Washington, DC: U.S. Department of Justice, 2006.
2. Rennison C. Rape and sexual assault: Reporting to police and medical attention, 1992-2000. Washington, D.C.: US Department of Justice, 2002.
3. Tjaden P, Thoennes N. Prevalence, incidence, and consequences of violence against women: Findings from the National Violence Against Women Survey. Washington, DC: U.S. Department of Justice, 1998.
4. Catalano SM. Criminal victimization, 2004. Washington, DC: U.S. Department of Justice, 2005.
5. Saltzman LE, Basile KC, Mahendra RR, Steenkamp M, Ingram E, Ikeda R. National estimates of sexual violence treated in emergency departments. Ann Emerg Med 2007;49:210.
6. Holmes MM, Resnick HS, Frampton D. Follow-up of sexual assault victims. Am J Obstet Gynecol 1998;179:336.
7. Sexually transmitted diseases treatment guidelines, 2002. Centers for Disease Control and Prevention. MMWR 2002;51(RR-6):1.
8. 1993 Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. MMWR 1993;42(RR-14):1.
9. 1998 Guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR 1998;47(RR-1):1.
10. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR 2006;55(RR-11):1.
11. Amey AL, Bishai D. Measuring the quality of medical care for women who experience sexual assault with data from the National Hospital Ambulatory Medical Care Survey. Ann Emerg Med 2002;39:631.
12. Rovi S, Shimoni N. Prophylaxis provided to sexual assault victims seen at U.S. emergency departments. J Am Med Womens Assoc 2002;57:204.
13. Merchant RC, Mayer KH, Browning CA, Nonocupational HIV PEP Task Force. Nonoccupational HIV postexposure prophylaxis: Guidelines for Rhode Island from the Brown University AIDS Program and the Rhode Island Department of Health. Providence, RI, 2002.
14. International classification of disease, 9th revision. Washington, DC: Department of Health and Human Services, 2001.
15. Riggs N, Houry D, Long G, Markovchick V, Feldhaus KM. Analysis of 1,076 cases of sexual assault. Ann Emerg Med 2000;35:358.
16. Linden JA, Oldeg P, Mehta SD, McCabe KK, LaBelle C. HIV postexposure prophylaxis in sexual assault: Current practice and patient adherence to treatment recommendations in a large urban teaching hospital. Acad Emerg Med 2005;12:640.
17. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1998 352:428.
18. Rodrigues I, Grou F, Joly J. Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse. Am J Obstet Gynecol 2001;184:531.
19. Ellertson C, Evans M, Ferden S, et al. Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours. Obstet Gynecol 2003;101:1168.